Author:
Regierer A. C.,Weiß A.,Baraliakos X.,Zink A.,Listing J.,Strangfeld A.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Baeten D, Sieper J, Braun J et al (2015) Secukinumab, an Interleukin-17A inhibitor, in Ankylosing Spondylitis. N Engl J Med 373:2534–2548
2. Baganz L, Richter A, Kekow J et al (2018) Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort. Rheumatol Int 38:579–587
3. Blanco FJ, Moricke R, Dokoupilova E et al (2017) Secukinumab in active rheumatoid arthritis: a phase III randomized, double-blind, active Comparator- and placebo-controlled study. Arthritis Rheumatol 69:1144–1153
4. Braun J (2016) New targets in psoriatic arthritis. Rheumatology (Oxf) 55:ii30–ii37
5. Coates LC, Kavanaugh A, Mease PJ et al (2016) Group for research and assessment of psoriasis and Psoriatic arthritis 2015 treatment recommendations for Psoriatic arthritis. Arthritis Rheumatol 68:1060–1071
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献